Stefania Pipitone

455 total citations
22 papers, 175 citations indexed

About

Stefania Pipitone is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Stefania Pipitone has authored 22 papers receiving a total of 175 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in Stefania Pipitone's work include Renal cell carcinoma treatment (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Bladder and Urothelial Cancer Treatments (5 papers). Stefania Pipitone is often cited by papers focused on Renal cell carcinoma treatment (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Bladder and Urothelial Cancer Treatments (5 papers). Stefania Pipitone collaborates with scholars based in Italy, United Kingdom and Sudan. Stefania Pipitone's co-authors include Stefano Cascinu, Laura Cortesi, Claudia Omarini, Giorgia Guaitoli, Federico Piacentini, Luca Moscetti, Maria Giuseppa Vitale, Cinzia Baldessari, Roberto Sabbatini and Massimo Dominici and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Annals of Oncology.

In The Last Decade

Stefania Pipitone

20 papers receiving 172 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefania Pipitone Italy 7 101 62 56 48 24 22 175
Floriana Camarda Italy 7 136 1.3× 46 0.7× 89 1.6× 44 0.9× 24 1.0× 27 236
Rebeca Lozano Spain 6 94 0.9× 151 2.4× 61 1.1× 60 1.3× 18 0.8× 21 207
Míriam Arumí Spain 5 113 1.1× 80 1.3× 33 0.6× 47 1.0× 18 0.8× 13 172
Nusayba A. Bagegni United States 9 154 1.5× 89 1.4× 47 0.8× 104 2.2× 13 0.5× 29 223
Clare Bartos United Kingdom 9 74 0.7× 39 0.6× 92 1.6× 64 1.3× 26 1.1× 13 246
Ruping Zhao China 10 89 0.9× 88 1.4× 121 2.2× 96 2.0× 27 1.1× 26 261
Mariko Tabata Japan 5 47 0.5× 44 0.7× 77 1.4× 49 1.0× 19 0.8× 12 148
Phuong Vu Norway 7 139 1.4× 64 1.0× 107 1.9× 106 2.2× 20 0.8× 12 258
David Morris United States 8 68 0.7× 102 1.6× 64 1.1× 39 0.8× 65 2.7× 25 224
Anishka D'souza United States 6 87 0.9× 95 1.5× 66 1.2× 55 1.1× 57 2.4× 25 201

Countries citing papers authored by Stefania Pipitone

Since Specialization
Citations

This map shows the geographic impact of Stefania Pipitone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefania Pipitone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefania Pipitone more than expected).

Fields of papers citing papers by Stefania Pipitone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefania Pipitone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefania Pipitone. The network helps show where Stefania Pipitone may publish in the future.

Co-authorship network of co-authors of Stefania Pipitone

This figure shows the co-authorship network connecting the top 25 collaborators of Stefania Pipitone. A scholar is included among the top collaborators of Stefania Pipitone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefania Pipitone. Stefania Pipitone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pipitone, Stefania, Maria Giuseppa Vitale, Roberto Sabbatini, et al.. (2026). Molecular Landscape of Advanced Endometrial Cancer: Exploratory Analyses at Modena Cancer Center (MEMO). International Journal of Molecular Sciences. 27(2). 1096–1096.
2.
Pipitone, Stefania, et al.. (2025). Extravasation of enfortumab vedotin: a case report and literature review on antibody-drug conjugates. European Journal of Hospital Pharmacy. ejhpharm–2024.
3.
Pipitone, Stefania, et al.. (2024). New Advances in Metastatic Urothelial Cancer: A Narrative Review on Recent Developments and Future Perspectives. International Journal of Molecular Sciences. 25(17). 9696–9696. 4 indexed citations
4.
Pipitone, Stefania, et al.. (2024). Homologous Recombination Repair Deficiency in Metastatic Prostate Cancer: New Therapeutic Opportunities. International Journal of Molecular Sciences. 25(9). 4624–4624. 1 indexed citations
5.
Baldessari, Cinzia, Stefania Pipitone, Maria Giuseppa Vitale, et al.. (2024). Molecular characterization as new driver in prognostic signatures and therapeutic strategies for endometrial cancer. Cancer Treatment Reviews. 126. 102723–102723. 4 indexed citations
6.
Vitale, Maria Giuseppa, Cinzia Baldessari, Stefania Pipitone, et al.. (2024). Pembrolizumab in Vaginal Carcinoma: A Case Report and Review of the Literature. SHILAP Revista de lepidopterología. 17(1). 564–572. 1 indexed citations
7.
Mastrolia, Ilenia, Stefania Pipitone, Maria Giuseppa Vitale, et al.. (2023). Chasing the Role of miRNAs in RCC: From Free-Circulating to Extracellular-Vesicle-Derived Biomarkers. Biology. 12(6). 877–877. 2 indexed citations
8.
Baldessari, Cinzia, et al.. (2023). De Novo Metastatic Prostate Cancer: Are We Moving toward a Personalized Treatment?. Cancers. 15(20). 4945–4945. 10 indexed citations
9.
Baldessari, Cinzia, Stefania Pipitone, Giuseppe Pugliese, et al.. (2023). Bone Metastases and Health in Prostate Cancer: From Pathophysiology to Clinical Implications. Cancers. 15(5). 1518–1518. 18 indexed citations
10.
Baldessari, Cinzia, Elena Zunarelli, Stefania Pipitone, et al.. (2023). Cerebellar metastasis of ovarian cancer: a case report. Journal of Medical Case Reports. 17(1). 553–553. 3 indexed citations
11.
12.
Iacovelli, Roberto, Chiara Ciccarese, Melissa Bersanelli, et al.. (2023). 1884MO Phase II study of avelumab (Ave) plus intermittent axitinib (Axi) in previously untreated patients (pts) with metastatic renal cell carcinoma (mRCC): The TIDE-A study. Annals of Oncology. 34. S1013–S1013. 2 indexed citations
13.
Pipitone, Stefania, et al.. (2023). Immunotherapy in urothelial cancer: current status and future directions. Expert Review of Anticancer Therapy. 23(11). 1141–1155. 12 indexed citations
14.
Pipitone, Stefania, Maria Giuseppa Vitale, Cinzia Baldessari, Massimo Dominici, & Roberto Sabbatini. (2021). Long survival of a young patient with Xp11.2 translocation metastatic clear cell renal carcinoma: case report. Tumori Journal. 107(6). NP131–NP135. 2 indexed citations
15.
Salati, Massimiliano, Stefania Pipitone, Margherita Rimini, et al.. (2019). Immune-inflammatory and clinicopathologic prognostic factors in a Western cohort of resected gastric cancers (GCs). Annals of Oncology. 30. iv75–iv75. 1 indexed citations
16.
Vitale, Maria Giuseppa, Cinzia Baldessari, Michèle Milella, et al.. (2019). Immunotherapy in Dialysis-Dependent Cancer Patients: Our Experience in Patients With Metastatic Renal Cell Carcinoma and a Review of the Literature. Clinical Genitourinary Cancer. 17(5). e903–e908. 25 indexed citations
17.
Toss, Angela, Marta Venturelli, Eleonora Molinaro, et al.. (2019). Hereditary Pancreatic Cancer: A Retrospective Single-Center Study of 5143 Italian Families with History of BRCA-Related Malignancies. Cancers. 11(2). 193–193. 14 indexed citations
18.
Omarini, Claudia, Giorgia Guaitoli, Stefania Pipitone, et al.. (2018). Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going. Cancer Management and Research. Volume 10. 91–103. 56 indexed citations
19.
20.
Andrikou, Kalliopi, et al.. (2017). Emerging antibodies for the treatment of pancreatic cancer. Expert Opinion on Emerging Drugs. 22(1). 39–51. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Floriana Camarda Breakdown of academic impact, for papers by Rebeca Lozano Breakdown of academic impact, for papers by Míriam Arumí Breakdown of academic impact, for papers by Nusayba A. Bagegni Breakdown of academic impact, for papers by Clare Bartos Breakdown of academic impact, for papers by Ruping Zhao Breakdown of academic impact, for papers by Mariko Tabata Breakdown of academic impact, for papers by Phuong Vu Breakdown of academic impact, for papers by David Morris Breakdown of academic impact, for papers by Anishka D'souza
Rankless by CCL
2026